Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands
Abstract Pleural mesothelioma (PM) is a lethal cancer often linked to asbestos exposure. The COVID-19 pandemic caused a global health crisis, raising concerns about its impact on cancer diagnoses and treatments. In response to the immense pressures on the healthcare system caused by the COVID-19 pan...
Saved in:
| Main Authors: | Illaa Smesseim, Li-Anne H. Douma, Jacobus A. Burgers, Ronald A. M. Damhuis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10054-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma
by: Adamic Katja, et al.
Published: (2025-06-01) -
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
by: Margaret Stalker, MD, et al.
Published: (2025-05-01) -
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities
by: Teodora Zahiu, et al.
Published: (2025-05-01) -
Miliary Mesothelioma
by: Dujinthan Jayabalan, et al.
Published: (2025-03-01) -
The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
by: Haoyu Wang, et al.
Published: (2025-01-01)